[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Meningococcal Conjugate Vaccine Market Professional Survey Report 2018

June 2018 | 107 pages | ID: G3585211E7EEN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Meningococcal Conjugate Vaccine market status and forecast, categorizes the global Meningococcal Conjugate Vaccine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The global Meningococcal Conjugate Vaccine market is valued at xx million US$ in 2017 and is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
  • North America
  • Europe
  • China
  • Japan
  • India
  • Southeast Asia
  • Other regions (Central & South America, Middle East & Africa)
The regional scope of the study is as follows:
  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Menactra
  • MENVEO
By Application, the market can be split into
  • Children
  • Adults
The study objectives of this report are:
  • To analyze and study the global Meningococcal Conjugate Vaccine capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
  • Focuses on the key Meningococcal Conjugate Vaccine manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Meningococcal Conjugate Vaccine are as follows:
  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Meningococcal Conjugate Vaccine Manufacturers
Meningococcal Conjugate Vaccine Distributors/Traders/Wholesalers
Meningococcal Conjugate Vaccine Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Meningococcal Conjugate Vaccine market, by end-use.
Detailed analysis and profiles of additional market players.
Global Meningococcal Conjugate Vaccine Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF MENINGOCOCCAL CONJUGATE VACCINE

1.1 Definition and Specifications of Meningococcal Conjugate Vaccine
  1.1.1 Definition of Meningococcal Conjugate Vaccine
  1.1.2 Specifications of Meningococcal Conjugate Vaccine
1.2 Classification of Meningococcal Conjugate Vaccine
  1.2.1 Menactra
  1.2.2 MENVEO
1.3 Applications of Meningococcal Conjugate Vaccine
  1.3.1 Children
  1.3.2 Adults
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF MENINGOCOCCAL CONJUGATE VACCINE

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Meningococcal Conjugate Vaccine
2.3 Manufacturing Process Analysis of Meningococcal Conjugate Vaccine
2.4 Industry Chain Structure of Meningococcal Conjugate Vaccine

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF MENINGOCOCCAL CONJUGATE VACCINE

3.1 Capacity and Commercial Production Date of Global Meningococcal Conjugate Vaccine Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Meningococcal Conjugate Vaccine Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Meningococcal Conjugate Vaccine Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Meningococcal Conjugate Vaccine Major Manufacturers in 2017

4 GLOBAL MENINGOCOCCAL CONJUGATE VACCINE OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Meningococcal Conjugate Vaccine Capacity and Growth Rate Analysis
  4.2.2 2017 Meningococcal Conjugate Vaccine Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Meningococcal Conjugate Vaccine Sales and Growth Rate Analysis
  4.3.2 2017 Meningococcal Conjugate Vaccine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Meningococcal Conjugate Vaccine Sales Price
  4.4.2 2017 Meningococcal Conjugate Vaccine Sales Price Analysis (Company Segment)

5 MENINGOCOCCAL CONJUGATE VACCINE REGIONAL MARKET ANALYSIS

5.1 North America Meningococcal Conjugate Vaccine Market Analysis
  5.1.1 North America Meningococcal Conjugate Vaccine Market Overview
  5.1.2 North America 2013-2018E Meningococcal Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Meningococcal Conjugate Vaccine Sales Price Analysis
  5.1.4 North America 2017 Meningococcal Conjugate Vaccine Market Share Analysis
5.2 Europe Meningococcal Conjugate Vaccine Market Analysis
  5.2.1 Europe Meningococcal Conjugate Vaccine Market Overview
  5.2.2 Europe 2013-2018E Meningococcal Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2013-2018E Meningococcal Conjugate Vaccine Sales Price Analysis
  5.2.4 Europe 2017 Meningococcal Conjugate Vaccine Market Share Analysis
5.3 China Meningococcal Conjugate Vaccine Market Analysis
  5.3.1 China Meningococcal Conjugate Vaccine Market Overview
  5.3.2 China 2013-2018E Meningococcal Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2013-2018E Meningococcal Conjugate Vaccine Sales Price Analysis
  5.3.4 China 2017 Meningococcal Conjugate Vaccine Market Share Analysis
5.4 Japan Meningococcal Conjugate Vaccine Market Analysis
  5.4.1 Japan Meningococcal Conjugate Vaccine Market Overview
  5.4.2 Japan 2013-2018E Meningococcal Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2013-2018E Meningococcal Conjugate Vaccine Sales Price Analysis
  5.4.4 Japan 2017 Meningococcal Conjugate Vaccine Market Share Analysis
5.5 Southeast Asia Meningococcal Conjugate Vaccine Market Analysis
  5.5.1 Southeast Asia Meningococcal Conjugate Vaccine Market Overview
  5.5.2 Southeast Asia 2013-2018E Meningococcal Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2013-2018E Meningococcal Conjugate Vaccine Sales Price Analysis
  5.5.4 Southeast Asia 2017 Meningococcal Conjugate Vaccine Market Share Analysis
5.6 India Meningococcal Conjugate Vaccine Market Analysis
  5.6.1 India Meningococcal Conjugate Vaccine Market Overview
  5.6.2 India 2013-2018E Meningococcal Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Meningococcal Conjugate Vaccine Sales Price Analysis
  5.6.4 India 2017 Meningococcal Conjugate Vaccine Market Share Analysis

6 GLOBAL 2013-2018E MENINGOCOCCAL CONJUGATE VACCINE SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Meningococcal Conjugate Vaccine Sales by Type
6.2 Different Types of Meningococcal Conjugate Vaccine Product Interview Price Analysis
6.3 Different Types of Meningococcal Conjugate Vaccine Product Driving Factors Analysis
  6.3.1 Menactra of Meningococcal Conjugate Vaccine Growth Driving Factor Analysis
  6.3.2 MENVEO of Meningococcal Conjugate Vaccine Growth Driving Factor Analysis

7 GLOBAL 2013-2018E MENINGOCOCCAL CONJUGATE VACCINE SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Meningococcal Conjugate Vaccine Consumption by Application
7.2 Different Application of Meningococcal Conjugate Vaccine Product Interview Price Analysis
7.3 Different Application of Meningococcal Conjugate Vaccine Product Driving Factors Analysis
  7.3.1 Children of Meningococcal Conjugate Vaccine Growth Driving Factor Analysis
  7.3.2 Adults of Meningococcal Conjugate Vaccine Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF MENINGOCOCCAL CONJUGATE VACCINE

8.1 GlaxoSmithKline
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 GlaxoSmithKline 2017 Meningococcal Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 GlaxoSmithKline 2017 Meningococcal Conjugate Vaccine Business Region Distribution Analysis
8.2 Pfizer
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Pfizer 2017 Meningococcal Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Pfizer 2017 Meningococcal Conjugate Vaccine Business Region Distribution Analysis
8.3 Sanofi
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Sanofi 2017 Meningococcal Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Sanofi 2017 Meningococcal Conjugate Vaccine Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MENINGOCOCCAL CONJUGATE VACCINE MARKET

9.1 Global Meningococcal Conjugate Vaccine Market Trend Analysis
  9.1.1 Global 2018-2025 Meningococcal Conjugate Vaccine Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Meningococcal Conjugate Vaccine Sales Price Forecast
9.2 Meningococcal Conjugate Vaccine Regional Market Trend
  9.2.1 North America 2018-2025 Meningococcal Conjugate Vaccine Consumption Forecast
  9.2.2 Europe 2018-2025 Meningococcal Conjugate Vaccine Consumption Forecast
  9.2.3 China 2018-2025 Meningococcal Conjugate Vaccine Consumption Forecast
  9.2.4 Japan 2018-2025 Meningococcal Conjugate Vaccine Consumption Forecast
  9.2.5 Southeast Asia 2018-2025 Meningococcal Conjugate Vaccine Consumption Forecast
  9.2.6 India 2018-2025 Meningococcal Conjugate Vaccine Consumption Forecast
9.3 Meningococcal Conjugate Vaccine Market Trend (Product Type)
9.4 Meningococcal Conjugate Vaccine Market Trend (Application)

10 MENINGOCOCCAL CONJUGATE VACCINE MARKETING TYPE ANALYSIS

10.1 Meningococcal Conjugate Vaccine Regional Marketing Type Analysis
10.2 Meningococcal Conjugate Vaccine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Meningococcal Conjugate Vaccine by Region
10.4 Meningococcal Conjugate Vaccine Supply Chain Analysis

11 CONSUMERS ANALYSIS OF MENINGOCOCCAL CONJUGATE VACCINE

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL MENINGOCOCCAL CONJUGATE VACCINE MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Meningococcal Conjugate Vaccine
Table Product Specifications of Meningococcal Conjugate Vaccine
Table Classification of Meningococcal Conjugate Vaccine
Figure Global Production Market Share of Meningococcal Conjugate Vaccine by Type in 2017
Figure Menactra Picture
Table Major Manufacturers of Menactra
Figure MENVEO Picture
Table Major Manufacturers of MENVEO
Table Applications of Meningococcal Conjugate Vaccine
Figure Global Consumption Volume Market Share of Meningococcal Conjugate Vaccine by Application in 2017
Figure Children Examples
Table Major Consumers in Children
Figure Adults Examples
Table Major Consumers in Adults
Figure Market Share of Meningococcal Conjugate Vaccine by Regions
Figure North America Meningococcal Conjugate Vaccine Market Size (Million USD) (2013-2025)
Figure Europe Meningococcal Conjugate Vaccine Market Size (Million USD) (2013-2025)
Figure China Meningococcal Conjugate Vaccine Market Size (Million USD) (2013-2025)
Figure Japan Meningococcal Conjugate Vaccine Market Size (Million USD) (2013-2025)
Figure Southeast Asia Meningococcal Conjugate Vaccine Market Size (Million USD) (2013-2025)
Figure India Meningococcal Conjugate Vaccine Market Size (Million USD) (2013-2025)
Table Meningococcal Conjugate Vaccine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Meningococcal Conjugate Vaccine in 2017
Figure Manufacturing Process Analysis of Meningococcal Conjugate Vaccine
Figure Industry Chain Structure of Meningococcal Conjugate Vaccine
Table Capacity and Commercial Production Date of Global Meningococcal Conjugate Vaccine Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Meningococcal Conjugate Vaccine Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Meningococcal Conjugate Vaccine Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Meningococcal Conjugate Vaccine Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Meningococcal Conjugate Vaccine 2013-2018E
Figure Global 2013-2018E Meningococcal Conjugate Vaccine Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Meningococcal Conjugate Vaccine Market Size (Value) and Growth Rate
Table 2013-2018E Global Meningococcal Conjugate Vaccine Capacity and Growth Rate
Table 2017 Global Meningococcal Conjugate Vaccine Capacity (K Doses) List (Company Segment)
Table 2013-2018E Global Meningococcal Conjugate Vaccine Sales (K Doses) and Growth Rate
Table 2017 Global Meningococcal Conjugate Vaccine Sales (K Doses) List (Company Segment)
Table 2013-2018E Global Meningococcal Conjugate Vaccine Sales Price (USD/Dose)
Table 2017 Global Meningococcal Conjugate Vaccine Sales Price (USD/Dose) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Doses) of Meningococcal Conjugate Vaccine 2013-2018E
Figure North America 2013-2018E Meningococcal Conjugate Vaccine Sales Price (USD/Dose)
Figure North America 2017 Meningococcal Conjugate Vaccine Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Doses) of Meningococcal Conjugate Vaccine 2013-2018E
Figure Europe 2013-2018E Meningococcal Conjugate Vaccine Sales Price (USD/Dose)
Figure Europe 2017 Meningococcal Conjugate Vaccine Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Doses) of Meningococcal Conjugate Vaccine 2013-2018E
Figure China 2013-2018E Meningococcal Conjugate Vaccine Sales Price (USD/Dose)
Figure China 2017 Meningococcal Conjugate Vaccine Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Doses) of Meningococcal Conjugate Vaccine 2013-2018E
Figure Japan 2013-2018E Meningococcal Conjugate Vaccine Sales Price (USD/Dose)
Figure Japan 2017 Meningococcal Conjugate Vaccine Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Doses) of Meningococcal Conjugate Vaccine 2013-2018E
Figure Southeast Asia 2013-2018E Meningococcal Conjugate Vaccine Sales Price (USD/Dose)
Figure Southeast Asia 2017 Meningococcal Conjugate Vaccine Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Doses) of Meningococcal Conjugate Vaccine 2013-2018E
Figure India 2013-2018E Meningococcal Conjugate Vaccine Sales Price (USD/Dose)
Figure India 2017 Meningococcal Conjugate Vaccine Sales Market Share
Table Global 2013-2018E Meningococcal Conjugate Vaccine Sales (K Doses) by Type
Table Different Types Meningococcal Conjugate Vaccine Product Interview Price
Table Global 2013-2018E Meningococcal Conjugate Vaccine Sales (K Doses) by Application
Table Different Application Meningococcal Conjugate Vaccine Product Interview Price
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2017 GlaxoSmithKline Meningococcal Conjugate Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 GlaxoSmithKline Meningococcal Conjugate Vaccine Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2017 Pfizer Meningococcal Conjugate Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Pfizer Meningococcal Conjugate Vaccine Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2015 Sanofi Meningococcal Conjugate Vaccine Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2017 Sanofi Meningococcal Conjugate Vaccine Business Region Distribution
Figure Global 2018-2025 Meningococcal Conjugate Vaccine Market Size (K Doses) and Growth Rate Forecast
Figure Global 2018-2025 Meningococcal Conjugate Vaccine Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Meningococcal Conjugate Vaccine Sales Price (USD/Dose) Forecast
Figure North America 2018-2025 Meningococcal Conjugate Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure China 2018-2025 Meningococcal Conjugate Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure Europe 2018-2025 Meningococcal Conjugate Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Meningococcal Conjugate Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure Japan 2018-2025 Meningococcal Conjugate Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Figure India 2018-2025 Meningococcal Conjugate Vaccine Consumption Volume (K Doses) and Growth Rate Forecast
Table Global Sales Volume (K Doses) of Meningococcal Conjugate Vaccine by Type 2018-2025
Table Global Consumption Volume (K Doses) of Meningococcal Conjugate Vaccine by Application 2018-2025
Table Traders or Distributors with Contact Information of Meningococcal Conjugate Vaccine by Region


More Publications